Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia

Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) are clonal hematopoietic stem cell diseases arising from the bone marrow (BM), and approximately 30% of MDS eventually progress to AML, associated with increasingly aggressive neoplastic hematopoietic clones and poor survival. Dysregul...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xingcheng, Ma, Ling, Zhang, Xiaoying, Huang, Liang, Wei, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889667/
https://www.ncbi.nlm.nih.gov/pubmed/35236415
http://dx.doi.org/10.1186/s40164-022-00263-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889667/
https://www.ncbi.nlm.nih.gov/pubmed/35236415
http://dx.doi.org/10.1186/s40164-022-00263-4

Ejemplares similares